Is Towa’s Guidance For 2024 ‘Somewhat Mediocre?’
One Leading Market Analyst Unimpressed With Operating Profit Guide
Bringing in sales that translated to nearly $1.5bn last year, Japan’s Towa was feeling upbeat after a challenging few years, both for itself and the broader Japanese generics market. However, its financial guide for the next 12 months has left investors feeling cold.
